|
|
Preferred Name
|
English
|
|
|
Official Name
|
English
|
|
|
Common Name
|
English
|
|
TUMOR INFILTRATING LYMPHOCYTES, AUTOLOGOUS (FROM MELANOMA TUMORS)
|
|
|
Common Name
|
English
|
|
|
Brand Name
|
English
|
|
|
Common Name
|
English
|
|
Tumor-infiltrating lymphocytes (TIL). The process for manufacturing lifileucel begins at the clinical site with the excision of tumors of ? 1 cm from metastatic sites, including lymph nodes. Tumor tissue is placed in media and shipped by overnight courie
|
|
|
Common Name
|
English
|
|
|
Common Name
|
English
|
|
Autologous tumor-infiltrating lymphocytes (TIL) derived from the patient's own tumor.
|
|
|
Common Name
|
English
|
|
Human culture expanded activated autologous T cells for cell-based immunotherapy. The cell substance is a heterogeneous mixture consisting of CD4+ and CD8+ tumor-infiltrating lymphocytes (TIL), derived from isolated tumor biopsy of patients with melanoma
|
|
|
Common Name
|
English
|
|
|
Code
|
English
|
|
|
Common Name
|
English
|
|
An autologous CD4+ and CD8+ tumor infiltrating lymphocyte, derived from isolated metastatic melanoma cultured in the presence of feeder cells (irradiated allogeneic mononuclear cells from healthy donors), and human recombinant interleukin 2/Muromonab-CD3
|
|
|
Common Name
|
English
|
